NHS Framework Agreement for the supply of Icatibant and C1 Esterase products for the treatment of Hereditary Angioedema
NHS Englandgoods
What the buyer wrote
NHS Framework Agreement for the supply of Icatibant and C1-Esterase products for the treatment of Hereditary Angioedema. The framework will commence on 1st July 2018 for a period of 12 months until 30th June 2019, with options to extend up to a further 36 months.
Bid for this and lost? There is a short window in which the decision can be questioned.
Awarded to
Details
- What the buyer calls it
- NHS Framework Agreement for the supply of Icatibant and C1 Esterase products for the treatment of Hereditary Angioedema
- How they are buying
- Advertised, open to anyoneAny supplier could bid without being invited first.
- Type
- goods
- Suitable for small firms
- The buyer says yes. What that is worth
- Work starts
- 30 Jun 2018
- Work ends
- 30 Jun 2019
- Kind of work
- Pharmacy and medicines
Who the buyer named
Julian Farley was the named contact on this notice.